Inhalational exposure to nerve agents

Respiratory Care Clinics of North America

Volumn 10, Issue 1, 2004, Pages 59-74

  Niven, Alexander S ^a,b   Roop, Stuart A ^a,b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b WILLIAM BEAUMONT ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PYRIDINE ALOXIME METHIODIDE; ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANTIDOTE; ATROPINE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM HYPOCHLORITE; CHARCOAL; CHEMICAL WARFARE AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; HYPOCHLORITE SODIUM; IPRATROPIUM BROMIDE; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; MUSCARINIC RECEPTOR; MUSCLE RELAXANT AGENT; NICOTINIC RECEPTOR; ORGANOPHOSPHATE; ORGANOPHOSPHATE INSECTICIDE; OXIME DERIVATIVE; PHENTOLAMINE; PRALIDOXIME CHLORIDE; RESIN; ROCURONIUM; SARIN; STEROID; SUXAMETHONIUM; THIAMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABSORPTION; AEROSOL; AMNESIA; ARTIFICIAL VENTILATION; BRONCHOSPASM; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DEPRESSION; CHEMICAL WARFARE; DIGESTIVE SYSTEM FUNCTION DISORDER; DIPLOPIA; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DROWSINESS; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG EFFICACY; DRUG ELIMINATION; DRY SKIN; EMERGENCY HEALTH SERVICE; HEADACHE; HEALTH CARE PLANNING; HUMAN; HYPERTENSION; MYDRIASIS; NEUROTOXICITY; NOCICEPTIVE STIMULATION; NONHUMAN; PATHOGENESIS; PUBLIC HEALTH; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; REVIEW; SEIZURE; SIDE EFFECT; SYMPTOMATOLOGY; TACHYCARDIA; VAPOR; VISUAL IMPAIRMENT; XEROSTOMIA;

CHEMICAL WARFARE AGENTS; DISASTER PLANNING; HUMANS; LUNG; LUNG DISEASES; ORGANOTHIOPHOSPHORUS COMPOUNDS; PHOSPHORIC ACID ESTERS; SARIN; SOMAN; UNITED STATES;

EID: 1342304360     PISSN: 10785337     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-5337(03)00049-2     Document Type: Review

References (68)

1. Oberstarzt F. Consequences of chemical warfare [Section IX, Article I]. In: Proceedings of the Consultants' Committee on Pharmacology. Berlin, Germany: 1943. p. 230. [Translated by Office of Military Government for Germany (US), Office of Naval Advisor.]
2. Koelle G.B. Anticholinesterase agents. In: Goodman L.S. Gilman A. (Eds.), The pharmacologic basis of therapeutics 5th edition 1975 445 Macmillan New York
3. Sidell F.R. Nerve agents. In: Zajtchuk R. Bellamy R.F. (Eds.), Textbook of military medicine. Medical aspects of chemical and biological warfare 1997 129-179 Office of the Surgeon General, Department of the Army Washington (DC)
4. Compton J.A.F. Nerve agents. In: Military chemical and biological agents: chemical and toxicological properties 1987 135-188 Caldwell The Telford Press
5. Holstege C.P. Kirk M. Sidell F.R. Chemical warfare: nerve agent poisoning Crit Care Clin 13 4 1997 923-942
6. Office of the Surgeon General and US Army Program Manager for Chemical Demilitarization. Prehospital and hospital provider course syllabus-chemical stockpile emergency preparedness program. 1998.
7. Macilwain C. Study proves Iraq used nerve gas Nature 363 1993 3
8. Research: low doses of sarin may have long-term effects. Associated Press report Monday, Dec 23, 2002. Available at: http://www.cnn.com/2002/HEALTH/12/22/nerve.gas.exposure.ap/. Accessed January 6, 2003.
9. Morita H. Yanagisawa N. Nakajima T. Shimizu M. Hirabayashi H. Okudera H. et al. Sarin poisoning in Matsumoto, Japan Lancet 346 1995 290-293
10. Okumura T. Takasu N. Ishimatsu S. Miyanoki S. Mitsuhashi A. Kumada K. et al. Report on 640 victims of the Tokyo subway sarin attack Ann Emerg Med 28 2 1996 129-135
11. Benschop H.P. DeJong L.P. Toxokinetics of nerve agents. In: Somani S.M. Romano J.R. JA (Eds.), Chemical warfare agents: toxicity at low levels 2001 25-81 CRC Press Boca Raton (FL)
12. Kukkonen J. Riikonen K. Nikmo J. Jappinen A. Nieminen K. Modelling aerosol processes related to the atmospheric dispersion of sarin J Hazard Mater 85 3 2001 165-179
13. Oberst F.W. Koon W.S. Christensen M.K. Crook J.W. Cresthull P. Freeman G. Retention of inhaled sarin vapor and its effect on red blood cell cholinesterase activity in man Clin Pharmacol Ther 9 4 1968 421-427
14. Marrs T.C. Maynard R.L. Sidell F.R. A history of human studies with nerve agents. In: Marrs T.C. Maynard R.L. Sidell F.R. (Eds.), Chemical warfare agents: toxicology and treatment 1996 115-137 Wiley New York
15. Sidell F.R. Clinical considerations in nerve agent intoxication. In: Somani S.M. (Ed.), The book on chemical warfare agents 1992 155-194 Academic Press San Diego (CA)
16. Paton W.D.M. Vizi E.S. Zar M.A. The mechanism of acetylcholine release from parasympathetic nerves J Physiol 215 3 1971 819-848
17. Aas P. Veiteberg T. Fonnum F. In vitro effects of soman on bronchial smooth muscle Biochem Pharmacol 35 11 1986 1793-1799
18. Kuba K. Albuquerque E.X. Daly J. Barnard E.A. A study of the irreversible cholinesterase inhibitor, diisopropylfluorophosphate, on time course of end plate currents in frog sartorius muscle J Pharmacol Exp Ther 189 2 1974 499-512
19. Ludomirsky A. Klein H.O. Sarelli P. Becker B. Hoffman S. Taitelman U. et al. Q-T prolongation and polymorphous ("torsade de pointes") ventricular arrhythmias associated with organophosphorus insecticide poisoning Am J Cardiol 49 7 1982 1654-1658
20. Namba T. Greenfield M. Grob D. Malathion poisoning Arch Environ Health 21 1970 533-541
21. Singer A.W. Jaax N.K. Graham J.S. McLeod Jr. C.G. Cardiomyopathy in soman and sarin intoxicated rats Toxicol Lett 36 1987 243-249
22. 3H]dipropylxanthine) to adenosine receptors in ovine cardiac membranes J Appl Toxicol 11 1991 411-414
23. Li C. Miller W.T. Jiang J. Pulmonary edema due to ingestion of organophosphate insecticide Am J Roentgenol 152 1989 265-266
24. Wright P.G. An analysis of the central and peripheral components of respiratory failure produced by acetylcholinesterase poisoning in the rabbit J Physiol 126 1954 52-70
25. Rickett D.L. Glenn J.F. Beers E.T. Central respiratory effects versus neuromuscular actions of nerve agents Neurotoxicology 7 1986 225-236
26. Abraham R.B. Rudick V. Weinbroum A.A. Practical guidelines for acute care of victims of bioterrorism: conventional injuries and concomitant nerve agent intoxication Anesthesiology 97 4 2002 989-1004
27. Fiori G. Saglini V. Bertini F. Domenighetti G. Mombelli G. Severe poisoning with the organophosphorus insecticide thionazine-2 cases with the development of adult respiratory distress syndrome (ARDS) Schweiz Med Wochenschr 117 11 1987 399-401
28. Romano Jr. J.A. McDonough J.H. Sheridan R. Sidell F.R. Health effects of low-level exposure to nerve agents. In: Somani S.M. Romano Jr. J.A. (Eds.), Chemical warfare agents: toxicity at low levels 2001 1-24 CRC Press Boca Raton (FL)
29. Rocha E.S. Santos M.D. Chebabo S.R. Aracava Y. Albuquerque E.X. Low concentrations of the organophosphate VX affect spontaneous and evoked transmitter release from hippocampal neurons: toxicological relevance of cholinesterase-independent actions Toxicol Appl Pharmacol 159 1999 31-40
30. Adams G.K. Yamamura H.I. O'Leary J.F. Recovery of central respiratory function following anticholinesterase intoxication Eur J Pharmacol 38 1 1976 101-112
31. Anzueto A. Berdine G. Moore G. et al. Pathophysiology of soman intoxication in primates Toxicol Appl Pharmacol 86 1986 56
32. Johnson R.P. Gold A.J. Freeman G. Comparative lung-airway resistance and cardiovascular effects in dogs and monkeys following parathion and sarin intoxication Am J Physiol 192 3 1958 581-584
33. Decandole C.A. Douglas W.W. Evans C.L. Holmes R. Spencer K.E.V. Torrance R.W. et al. The failure of respiration in death by acetylcholinesterase poisoning Br J Pharmacol 8 1953 466-475
34. Oberst F.W. Factors affecting inhalation and retention of toxic vapors. In: Davies C.N. (Ed.), Inhaled particles and vapours 1961 249-265 Pergamon Press New York
35. Bardin P.G. Van Eeden S.F. Joubert J.R. Intensive care management of acute organophosphate poisoning. A 7-year experience in the Western Cape S Afr Med J 72 1987 593-597
36. Berkenstadt H. Marganitt B. Atsmon J. Combined chemical and conventional injuries: pathophysiological, diagnostic and therapeutic aspects Isr J Med Sci 27 1991 623-626
37. Hurst C.G. Decontamination. In: Zajtchuk R. Bellamy R.F. (Eds.), Textbook of military medicine. Medical aspects of chemical and biological warfare 1997 351-359 Office of the Surgeon General, Department of the Army Washington DC
38. Baker D.J. Management of respiratory failure in toxic disasters Resuscitation 42 1999 125-131
39. Shemesh I. Bourvin A. Gold D. Kutscherowsky M. Chlorpyrifos poisoning treated with ipratropium and dantrolene: a case report J Toxicol Clin Toxicol 26 7 1988 495-498
40. Shockley L.W. The use of inhaled nebulized atropine for the treatment of malathion poisoning J Toxicol Clin Toxicol 27 3 1989 183-192
41. Leikin J.B. Thomas R.G. Walter F.G. Klein R. Meislin H.W. A review of nerve agent exposure for the critical care physician Crit Care Med 30 10 2002 2346-2354
42. LeBlanc F.N. Benson B.E. Gilg A.D. A severe organophosphate poisoning requiring the use of an atropine drip J Toxicol Clin Toxicol 24 1986 69-76
43. Robinson S. Magenis T.P. Minter D.I. Harper H. The effects of varying doses of atropine on temperature regulation of men and dogs. In: Robinson S. (Ed.), The physiological effects of atropine and potential atropine substitutes. Medical Laboratory Contract Report 15 1953 Medical Research Laboratories Edgewood Arsenal (MD)
44. Wills J.H. McNamara B.P. Fine E.A. Ventricular fibrillation in delayed treatment of TEPP poisoning [abstract] Fed Proc 9 1950 136
45. Sundwall A. Minimal concentrations of N-methylpyridinium-2-aloxime methane sulphonate (P2S) which reverse neuromuscular block Biochem Pharmacol 8 1961 413-417
46. Marrs T.C. Maynard R.L. Sidell F.R. Organophosphate nerve agents. In: Marrs T.C. Maynard R.L. Sidell F.R. (Eds.), Chemical warfare agents: toxicology and treatment 1996 83-100 Wiley New York
47. Josselson J. Sidell F.R. Effect of intravenous thiamine on pralidoxime kinetics Clin Pharmacol Ther 24 1 1978 95-100
48. Calesnick B. Christensen J.A. Richter M. Human toxicity of various oximes Arch Environ Health 15 1967 599-608
49. Treiman D.M. Meyers P.D. Walton N.Y. Collins J.F. Colling C. Rowan J. et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group N Engl J Med 339 12 1998 792-798
50. Yokoyama K. Orura Y. Kishimoto M. Hinoshita F. Hara S. Yamada A. et al. Blood purification for severe sarin poisoning after the Tokyo subway attack JAMA 274 5 1995 379
51. Talbot B.G. Anderson D.R. Harris L.W. Yarbrough L.W. Lennox W.J. A comparison of in vivo and in vitro rates of aging of soman-inhibited erythrocyte acetylcholinesterase in different animal species Drug Chem Toxicol 11 1988 289-305
52. Von Bredow J.D. Adams N.L. Groff W.A. Vick J.A. Effectiveness of oral pyridostigmine pretreatment and cholinolytic-oxime therapy against soman intoxication in nonhuman primates Fundam Appl Toxicol 17 1991 761-770
53. Somani S.M. Husain K. Jagannathan R. Pharmacokinetics and pharmacodynamics of carbamates under physical stress. In: Somani S.M. Romano Jr. J.A. (Eds.), Chemical warfare agents: toxicity at low levels 2001 145-189 CRC Press Boca Raton (FL)
54. Ram Z. Molcho M. Danon Y.L. Almog S. Baniel J. Karni A. et al. The effect of pyridostigmine on respiratory function in healthy and asthmatic volunteers Isr J Med Sci 27 1991 664-668
55. Keeler J.R. Hurst C.G. Dunn M.A. Pyridostigmine used as a nerve agent pretreatment under wartime conditions JAMA 266 1991 693-695
56. Cook J.E. Kolka M.A. Chronic pyridostigmine bromide administration: side effects among soldiers working in a desert environment Mil Med 157 1992 250-254
57. Somani S.M. Husain K. Low-level nerve agent toxicity under normal and stressful conditions. In: Somani S.M. Romano Jr. J.A. (Eds.), Chemical warfare agents: toxicity at low levels 2001 83-120 CRC Press Boca Raton (FL)
58. Lotti M. Becker C.E. Aminoff M.J. Organophosphate polyneuropathy: pathogenesis and prevention Neurology 34 1984 658-662
59. Senanayake N. Karalliedde L. Neurotoxic effects of organophosphorus insecticides: an intermediate syndrome N Engl J Med 316 13 1987 761-763
60. Jamal G.A. Hansen S. Apartopoulos F. Peden A. The "Gulf War Syndrome": is there evidence of dysfunction in the nervous system? J Neurol Neurosurg Psychiatry 60 1996 449-451
61. Davis D.R. Holland P. Rheumens M.J. The relationship between the chemical structures and neurotoxicity if alkyl organophosphorus compounds Br J Pharmacol 15 1960 271
62. Merrill D.G. Mihm F.G. Prolonged toxicity of organophosphate poisoning Crit Care Med 10 8 1982 550-551
63. Routier R.J. Lipman J. Brown K. Difficulty weaning from respiratory support in a patient with the intermediate syndrome of organophosphate poisoning Crit Care Med 17 10 1989 1075-1076
64. Nakajima T. Ohta S. Fukushima Y. Yanagisawa N. Sequelae of sarin toxicity at one and three years after exposure in Matsumoto, Japan J Epidemiol 9 5 1999 337-343
65. Rastogi S.K. Gupta B.N. Husain T. Mathur N. Garg N. Study of respiratory impairment among pesticide sprayers in mango plantations Am J Ind Med 16 5 1989 529-538
66. Martyny J. Glazer C.S. Newman L.S. Respiratory protection N Engl J Med 347 11 2002 824-830
67. National Institute for Occupational Safety and Health Occupational safety and health guidance manual for hazardous waste site activities 1985 US Department of Health and Human Services Washington, DC
68. O'Hern M.R. Dashiell T.R. Tracy M.F. Chemical defense equipment. In: Zajtchuk R. Bellamy R.F. (Eds.), Textbook of military medicine. Medical aspects of chemical and biological warfare 1997 361-396 Office of the Surgeon General, Department of the Army Washington DC